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Platelets shed microparticles not only upon activation, but also upon ageing by an apoptosis-like process (apoptosis-induced
platelet microparticles, PMap). While the activation-induced microparticles have widely been studied, not much is known about
the(patho)physiologicalconsequencesofPMapformation.Flowcytometryandscanningelectronmicroscopydemonstratedthat
PMap display activated integrins and interact to form microparticle aggregates. PMap were chemotactic for monocytic cells,
bound to these cells, an furthermore stimulated cell adhesion and spreading on a ﬁbronectin surface. After prolonged
incubation, PMap promoted cell differentiation, but inhibited proliferation. Monocyte membrane receptor analysis revealed
increased expression levels of CD11b (integrin aMb2), CD14 and CD31 (platelet endothelial cell adhesion molecule-1), and the
chemokine receptors CCR5 and CXCR4, but not of CCR2. This indicated that PMap polarized the cells into resident M2
monocytes. Cells treated with PMap actively consumed oxidized low-density lipoprotein (oxLDL), and released matrix
metalloproteinases and hydrogen peroxide. Further conﬁrmation for the differentiation towards resident professional
phagocytes came from the ﬁnding that PMap stimulated the expression of the (ox)LDL receptors, CD36 and CD68, and the
production of proinﬂammatory and immunomodulating cytokines by monocytes. In conclusion, interaction of PMap with
monocytic cells has an immunomodulating potential. The apoptotic microparticles polarize the cells into a resident M2 subset,
and induce differentiation to resident professional phagocytes.
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Thepresenceofmicroparticlesinplatelet-richplasmahasﬁrst
been described in the late 60s, where these were designated
as platelet dust.
1 Since that time, the role of platelet-derived
microparticles in the (patho)physiology of thrombosis
and haemostasis has been well established. Circulating
platelet microparticles in normal peripheral blood support
low-grade thrombin generation.
2 After surgery and under
thrombotic conditions, the levels of microparticles in plasma
can signiﬁcantly increase,
3,4 and this has been associated
with the pathologies of cardiovascular diseases,
5 inﬂamma-
tion and atherosclerosis. The formation of these micro-
particles is considered to be a consequence of platelet
activation with potent agonists, which indeed give rise to
massive shedding of ‘activation-induced’ microparticles with a
strong procoagulant potential in vitro.
6
Platelets circulate in blood for 9–10 days, and then are
cleared in the spleen or liver following an apoptotic-like
process.
7,8 This age-induced platelet apoptosis also leads to
shedding of microparticles but, markedly, this process is not
accompanied by signs of platelet activation.
9,10 Accordingly,
there is a continuous formation of apoptosis-induced platelet
microparticles (PMap) in blood from ageing, seemingly rest-
ing platelets. Phagocytes, including monocytes, dendritic
cells and macrophages, are responsible for the clearance of
apoptotic platelets and also PMap from the circulation.
11
Conditions stimulating platelet apoptosis or suppression of
phagocytosis will hence increase the plasma levels of PMap,
which may aggravate inﬂammation-linked disorders like
atherosclerosis.
Much attention has been paid to the microparticles that are
generated from activated platelets. For instance, their high
procoagulant potential has been characterized,
12 their pro-
teome with many bioactive compounds – including CCL5,
CXCL4 and CXCL7 – has been unraveled
13,14 and they
have recently been shown to enhance the vasoregenerative
potential of angiogenic early outgrowth cells.
15 Instead, there
is very little knowledge of biological effects of the ‘sponta-
neously’ formed apoptosis-induced microparticles, the PMap.
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www.nature.com/cddisHere, we hypothesized that PMap have an immunomodulating
role by interacting with leukocytes, in particular monocytes.
We aimed to characterize this role by determining short- and
long-term effects of the interactions of PMap with monocytic
cells and primary monocytes.
Results
Interactions of monocytic cells with PMap. Microparticle-
containing platelet-free plasma was isolated from stored
platelet–plasma concentrates (5 days of storage) in which
shed apoptotic microparticles accumulate time-depen-
dently without platelet activation
10 (Figure 1a, left panel),
as visualized by ﬂow cytometry using CD61 (glycoprotein
(GP)IIIa) expression as a platelet-speciﬁc marker (Figure 1a,
right panel). The plasma was microscopically checked for the
presence of PMap and absence of intact platelets. Using a
combination of micropore ﬁltering (0.8mm) and ultra-
centrifugation to remove intact platelets, PMap were isolated
and characterized by ﬂow cytometry, with freshly isolated
platelets as a reference. The PMap fraction mostly contained
particles of o1mm in size, but also appreciable numbers of
larger size particles (Figure 1b). These larger particles may
be aggregated PMap, as scanning electron microscopy
revealed the presence of single as well as aggregated
microparticles (Figure 1c). Flow cytometry characterization
further indicated that CD61 expression was lower in
PMap than in resting platelets (compatible with
the size difference), and that the activated conformation of
GPIIb/IIIa (detected with PAC1 monoclonal antibody (mAb))
was higher in PMap (Figures 1d and e). In PMap the
expression of markers of strong activation, for example,
CD62P (P-selectin) and phosphatidylserine (annexin A5
binding), were increased in comparison to resting platelets.
Together, this indicated that PMap assume an activation state
with procoagulant phospholipids and activated integrins, thus
explaining their ability to form aggregates.
WethenexaminedtheabilityofPMaptobindtoTHP-1cells,
an established monocytic cell line. Electron microscopy
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Figure 1 Characterization of apoptosis-induced platelet microparticles. (a) Spontaneous generation of PMap in platelets stored in RPMIþ5% FBS at 371C for 1–7
days (left panel) and ﬂow cytometry visualization of platelets and PMap (right panel, marked areas, AG: aggregates) and (b)o fP M ap isolated from 5-day-old platelet
concentrates. Stainingwas with FITC-labeledanti-CD61mAb,and1mm and6mm beads wereaddedas size markers (in frames). (c) Electronmicroscopy images of platelets
and of PMap, forming small aggregates (arrowsand right panel). (d) Flow cytometrydetection for resting platelets (plts) and PMap of expressionlevels of GPIIb/IIIa (FITC anti-
CD61mAb),activatedGPIIb/IIIa(FITCPAC1mAb),P-selectin(FITC-anti-CD62PmAb)andphosphatidylserine(APC-annexin A5).Mean±S.E.M.(n¼4–6).*Po0.05versus
platelets. (e) Representative histograms of the ﬂow cytometry analysis, ﬁlled histogram: (isotype) control, dashed line: platelets, solid line: PMap
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Cell Death and Diseasedetected multiple PMap on the surface of THP-1 cells
coincubated with the microparticles (Figure 2a). Flow cyto-
metry using anti-CD61mAb indicated that the PMap binding to
cells increased between 30min and 70min (Figures 2b
and c). At later time points, CD61 binding sites on the cell
surface decreased again. This suggested that the PMap were
internalized by endocytosis, which could be conﬁrmed by
confocal microscopy revealing PMap localized at the surface
and in the cytoplasm of the THP-1 cells (Figure 2d and
Supplemental movie). Binding was completely absent after
heat treatment of PMap (561C for 30min, data not shown),
indicating the necessity for active adhesion molecules on
the PMap surface for interaction with monocytic cells. To
determine whether PMap contain biological activity towards
blood cells, we used a Transwell migration assay detecting
chemotactic effects on THP-1 cells. Strikingly, PMap evoked
robust cell migration, which was comparable with the
reference chemokine, CCL2 (Figure 2e), indicating a strong
chemotactic potential of the microparticles. To further
investigate the potential mediators derived from PMap,w e
employed blocking antibodies against CCL5 and CXCL7, two
platelet-derivedchemokinesthathavebeenshowntomediate
mononuclear cell (MC) recruitment.
16 The chemotaxis of
THP-1 cells toward PMap could be effectively blocked with
antibodies against CCL5, whereas anti-CXCL7 or isotype
antibodies showed no effect (Figure 2e). This suggests that
CCL5 is a major factor that controls monocyte migration in the
direction of PMap.
PMap-induced adhesion of monocytic cells under static
and ﬂow conditions. Experiments were conducted to
determine the functional consequences of monocytic cell
interactions with PMap. Preincubation of THP-1 cells with
PMap (44h) caused a marked increase in stable adhesion to
ﬁbronectin-coated wells under static conditions. This effect
was similarly effective to that of incubation with phorbol
myristate acetate (PMA; Figure 3a). It tended to increase
with higher counts of PMap, whereas supernatants from PMap
preparations were inactive. Also, preincubation with resting
platelets, added at similar counts, did not affect the adhesion.
As platelets spontaneously shed PMap, the generation of
PMap during the course of the coincubation experiments with
resting platelets might inﬂuence our ﬁndings (Figure 1a). In
order to exclude potential effects from these spontaneously
generated PMap, we ﬁrst determined the amount of PMap
formed after 7 days relative to the 10/1 ratio of PMap that we
commonly used in our experiments (Figure 3b). In a
subsequent adhesion assay, we compared the functional
effects of this amount of PMap with the 10/1 ratio of PMap.A s
expected, no effects of this minor amount of PMap were
observed (Figure 3c).
The effect of PMap on adhesion of primary monocytes was
studied under physiological conditions of low-shear ﬂow over
a conﬂuent monolayer of human endothelial cells.
17 Coin-
cubation with PMap (44h) dramatically stimulated the adhe-
sion of isolated monocytes to the endothelium, whereas
coincubation with platelets at similar counts had no effect
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Figure 2 Inﬂuence and interaction of PMap with monocytes. (a) Electron microscopy image of multiple PMap bound to THP-1 cells after 30min of coincubation.
(b)FlowcytometrydetectionofPMaporrestingplatelets(plts)bindingtoTHP-1cells(FI).Cells(2 10
6cells/ml)wereincubatedwithvehiclecontrol(ctrl),PMap(2 10
8cells/
ml),or platelets(2 10
8cells/ml)for30–180min.Coaggregates with THP-1cellswerestainedwith FITCanti-CD61mAb. Mean±S.E.M.(n¼4–6).*Po0.05versuscontrol,
1Po0.05 versus 70min time point. (c) Representative histograms of ﬂuorescence changes in THP-1 cells due to PMap binding. Note secondary decrease after 180min
incubation, indicative for internalization. (d) Confocal microscopy of THP-1 cells coincubated with PMap for 4h at RT. Scale bar: 10mm, green ﬂuorescence: CD61, red
ﬂuorescence: CD45. (e) In Transwell chambers, the number of THP-1 cells migrated during 24h towards PMap (10
8cells/ml) was measured in the lower chambers. CCL2
(50ng/ml) wasusedasapositivecontrol.Additionally,PMapwerepreincubatedwithanti-CCL5,anti-CXCL7andisotypeIgG1mAb(10mg/ml,40minatRT),andcellswereleft
for transmigration. Mean±S.E.M. (n¼3). *Po0.05 versus control, 1Po0.05 versus PMap and anti-CCL5mAb
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Cell Death and Disease(Figure 3d). Treatment with PMap thus stimulates the
adhesive properties of both the monocytic cell line and
primary monocytes.
PMap-induced differentiation to professional resident
phagocytes. Changes in monocytic cell surface receptors
were studied by ﬂow cytometry after short-term (44h) or
long-term (7 days) incubation with or without PMap. The
presence of PMap gradually increased the expression
levels of CD11b (integrin aMb2), CD14 (lipopolysaccharide
co-receptor) and CD31 (platelet endothelial cell adhesion
molecule-1) in similar ways for THP-1 cells (Figure 4a) and
for primary monocytes (Figure 4b). The presence of PMap
downregulated the expression of CCR2 (CCL2 receptor)
both on THP-1 cells and monocytes after 44h, although the
expression of this receptor recovered after 7 days.
By contrast, PMap signiﬁcantly increased the level of CCR5
(CCL5 receptor) in THP-1 cells, but not in primary
monocytes, and increased the level of CXCR4 (CXCL12
receptor) both in THP-1 cells and primary monocytes
(Figures 4a and b). Jointly this suggested that PMap-treated
monocytic cells tend to assume a resident (M2) monocyte
phenotype, which previously has been deﬁned as
CD14
þCD16
þCCR2
 CCR5
þCXCR4
þþ.
18 Expression
levels of CD16 (FcgRIII receptor) remained unchanged in
our experiments (Figures 4a and b).
Prolonged incubation of THP-1 cells with PMap stimulated
spreading of the cells on a ﬁbronectin surface (Figure 5a).
Spreading involved the formation of ﬁlopods and lamellipods,
which appeared as actin ﬁlament bundles upon staining
with the actin probe, phalloidin (Figure 5a). It was also found
that the presence of PMap essentially annulled the proli-
feration of THP-1 cells (Figure 5b). Control staining with
ethidium bromide showed that the non-viable cells remained
at 6–7% after treatment with PMA, PMap or resting platelets
(Figure 5c). Collectively, these ﬁndings supported the
conclusion that THP-1 cells in the presence of PMap develop
to a resident, non-proliferating phagocytic phenotype.
Further experiments were carried out to conﬁrm the
differentiation into professional phagocytic cells. Prolonged,
7-dayincubation of THP-1 cells with PMap, but not with resting
platelets, increased the uptake of oxidized low-density
lipoprotein (oxLDL; Figure 5d). In agreement with this,
the surface expression of the respective oxLDL and LDL
receptors CD36 and CD68 (macrophage differentiation
markers) was increased in the presence of PMap
(Figure 5e). Similarly, incubation of primary monocytes with
PMap for 7 days increased the CD36 level, but this period
appeared to be too short to alter the CD68 expression
(Figure 5f).
PMap-induced secretory properties of monocytic
cells. Resident phagocytic monocytes are characterized by
their capability to secrete matrix-degrading proteinases and
reactive oxygen species.
19 Indeed, incubation of THP-1 cells
with PMap, but not resting platelets, for 2–7 days resulted in
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Figure 3 Adhesion of monocytic cells induced by PMap.( a) Static adhesion to a ﬁbronectin surface after 44h incubation of THP-1 cells (1.5 10
5cells/ml) with
vehiclecontrol(ctrl),PMap(ratiopercell,10/1or30/1),restingplatelets(plts;ratiopercell,10/1or30/1)orsupernatantfromcentrifugedPMap(sup).Aspositivecontrol,THP-1
cells were incubated with PMA (10ng/ml). Note the increased adhesion with PMap in comparison to platelets. (b) The amount of PMap spontaneously generated during
incubation with platelets (black bar) compared with the experimentally used 10/1 ratio of PMap.( c) Static adhesion to a ﬁbronectin surface after 44h incubation of
THP-1 cells (1.5 10
5/ml) with vehicle (ctrl) and PMap (ratio per cell, 0.5/1 or 10/1). (d) Adhesion of primary monocytes during low-shear ﬂow over a monolayer of conﬂuent
endothelial cells. Monocytes were preincubated for 44h with vehicle control (ctrl), PMap (ratio, 10/1) or resting platelets (ratio, 10/1). Mean±S.E.M. (n¼3–4). *Po0.05
versus control, 1Po0.05 versus 0.5/1 ratio per cell (n¼3–5)
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Cell Death and Diseasethe production of functional matrix metalloproteinase
(MMP)9, as was shown by zymography (Figure 6a). Quanti-
ﬁcation of the zymograms indicated a time-dependent
increase of MMP activity after PMap incubation, which was
similarly high as that of incubation with PMA after 7 days
(Figure 6b). This time effect also indicated that MMP derived
from PMap and platelets
20 themselves did not measurably
contribute to the zymographic activity of supernatants.
Furthermore, PMap incubation markedly enhanced the
release of hydrogen peroxide (H2O2) from both monocytic
cells (Figure 6c) and primary monocytes (Figure 6d).
To screen for the secretion of cytokines and chemokines,
primary monocytes were incubated for 44h with PMap or
resting platelets, after which cell supernatants were analyzed
for the presence of a panel of cytokines using a semi-
quantitative commercial array kit (Figure 7a). Markedly, in
comparison to platelets, the presence of PMap stimulated the
release of several cytokines and other factors known to be
proinﬂammatory, such as C5a, CCL5 and interleukin-23, and
to a lesser extent of macrophage migration inhibitory factor,
soluble CD40 ligand and soluble intercellular adhesion
molecule 1. Furthermore, the monocytes produced several
factors that participate in immunomodulating and regenera-
tive processes rather than in inﬂammation, such as granulo-
cyte colony-stimulating factor (G-CSF) and granulocyte
macrophage colony-stimulating factor (GM-CSF). To deter-
mine the most abundantly secreted relevant cytokines in a
more quantitative manner, we performed an enzyme-linked
immunosorbent assay (ELISA) for C5a, GM-CSF, interferon-g
(IFN-g)andtumornecrosisfactora(TNFa).Althoughsecreted
IFN-g levels were below detection limits, the ELISA measure-
ments largely conﬁrmed the induction of monocyte C5a,
GM-CSF and TNFa secretion by PMap, albeit that platelets
morepotentlyinducedGM-CSFproductioninmonocytesthan
PMap (Figure 7b).
Discussion
In the present paper, we have identiﬁed a potent modulating
role of PMap on monocyte functions. These microparticles,
formed by ageing platelets in an apoptosis-like process,
appear to display a characteristic ‘pro-adhesive’ membrane
surface with integrins (GPIIb/IIIa) in the activated conforma-
tion and exposure of phosphatidylserine, which may facilitate
the interaction with monocytes. In the literature, the formation
of platelet–leukocyte coaggregates is studied extensively, for
example, following activation of the platelet protease-acti-
vated receptor (thrombin receptor) and P2Y12 receptors. Very
little, however, is still known about the formation of platelet
microparticle–leukocyte complexes. The present study is the
ﬁrst to demonstrate the role of platelet microparticles,
produced from ageing, and apoptotic platelets in leukocyte
function and differentiation. Jointly our results show that PMap
interacting withmonocyticcellsandprimarymonocytesevoke
potent effects in achieving cell polarization and differentiation.
In our implemented model of coincubation of platelets and
PMap with monocytic cells in vitro, we took effort to exclude
confounding effects of PMap generated by platelets during the
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Cell Death and Diseaselong-term coculture process. Indeed, the amount of sponta-
neously generated PMap by platelets was found to be
functionally negligible.
The precise signaling pathways that are triggered in
monocytes by PMap still need to be identiﬁed. One con-
ceivablemechanismsupportedbyourﬁndingsistriggeringvia
chemokines such as CCL5, which is carried and secreted by
activated platelets
16,21,22 and activation-induced platelet
microparticles.
14,23 Such a mechanism explains the chemo-
tactic effect of PMap causing monocytic cell migration and has
recentlybeenimplied inthemodulationofT-celldifferentiation
by platelets.
24 In addition, the PMap-induced activation of
monocytes likely relies on speciﬁc molecular interactions with
receptors on the microparticle surface, including lipids
(phosphatidylserine),
25,26 adhesive receptors (for example,
activated GPIIb/IIIa) and GP counter-receptors (P-selectin),
similar to those identiﬁed for monocyte activation by plate-
lets.
22,27 Furthermore, also endocytosis of PMap following
adhesion may force the monocytes to enter speciﬁc differ-
entiation pathways. Interestingly, it appeared that the PMap-
induced adhesion to monocytic cells was abolished by cell
treatment with wortmannin, suggesting a role of phosphoino-
sitide 3-kinase signaling pathways in the monocyte activation
(E. Vasina, unpublished data and Barry et al.
28).
Circulating monocytes appear to form different subsets
with discrete properties and functions. A conventional division
is into ‘proinﬂammatory’ M1 monocytes, which secrete
proinﬂammatory cytokines and have a cytotoxic role, and
‘resident’ M2 monocytes, which participate in tissue remodel-
ing, wound healing and angiogenesis.
29 The M2 monocytes
tend to differentiate into professional phagocytes character-
ized by potent endocytotic activity.
18 Knowing that the
formation of resident monocytes is accompanied by down-
regulation of CCR2 and upregulation of CCR5 and CXCR4
surface receptors, we observed a marked potential of
PMap to differentiate monocytes in the direction of M2 cells
and professional phagocytes. This was conﬁrmed by an
increased expression of adhesive integrins (CD11b), of the
respective LDL and oxLDL receptors, CD68 and CD36, and a
higher uptake of oxLDL. In support of the notion that M2
monocytespreferentially differentiate into dendritic cells,
18 we
detected elevated amounts of GM-CSF in the secretome of
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Figure 5 Differentiation of monocytes into resident phagocytic cells induced by PMap.( a) Surface spreading and actin cytoskeleton rearrangements of THP-1 cells,
culturedfor7dayswith vehiclebufferorPMap.Bright-ﬁeldimagesindicatecellspreadingandﬁlopodformation(arrows);imagesofFITC-phalloidin ﬂuorescence showstrands
ofactinﬁlamentswithPMap(scalebars:100mm,representativeforthreeexperiments).(b)ProliferationofTHP-1cellsafter7daysofincubationwithvehicleorPMap.Dataare
expressed as absolute cell numbers. (c) Relative amount (%) of necrotic cells after incubation with PMA (10ng/ml), PMap, or resting platelets. (d) Uptake of oxLDL (labeled
withDiI)byTHP-1cells,incubatedfor7dayswithPMaporrestingplatelets(plts).(eandf,)ExpressionofphagocyticcellmarkersonTHP-1cells(e)andprimarymonocytes(f).
Cells were treated for 2 or 7 days with vehicle or PMap. Surface expression of CD36 was determined by ﬂow cytometry, as was the intracellular expression of CD68 in
permeabilized cells. Incubation conditions were as described for Figure 2. Mean±S.E.M. (n¼4–5). *Po0.05 versus control
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Cell Death and DiseasePMap-stimulated monocytes, a stimulus for differentiation to
dendritic cells.
30
The present ﬁndings likely have important implications for
our understanding of the pathology of atherosclerosis. Initial
support for a proatherogenic role of PMap-activated mono-
cytescomesfromtheirenhancedadhesiontoendothelialcells
under ﬂow conditions that precedes plaque inﬁltration and is
particularly relevant in early stages of atherosclerosis.
16 This
increased adhesion is likely mediated by receptors on the
microparticles or by an increased expression of adhesive
monocyte receptors (for example, CD11b, CD31)
22,31
and may be further augmented by the expression of
chemokines such as CCL5.
23 In addition, the monocyte
subset LyC
loCCR2
 CCR5
þ was shown to use the CCL5
receptor CCR5 when entering atherosclerotic plaques in
mice,
32 and the blocking of CCR5 led to a reduction of
atherosclerosis in several studies.
33 Analogously, in our
experiments, the polarization of human monocytes by PMap
into the CD14
þCD16
þCCR2
 CCR5
þCXCR4
þþ phenotype
is suggestive for the formation of a proatherogenic monocyte
subset, residing in human plaques and aggravating athero-
sclerosis. This suggestion is supported by the observation
that PMap-activated monocytic cells upregulate the expres-
sion of phagocyte markers (CD14, CD36, CD68), and
massively release MMP and H2O2, which are factors that
constitute to plaque destabilization and eventual rupture, a
clinically precipitating event in atherosclerotic disease.
Earlier studies have shown that the production of PMap
is a continuous process in stored platelets in the apparent
absence of platelet activation.
10 In the circulation, like other
apoptotic bodies, these microparticles will be actively re-
moved by binding and phagocytosis.
11 Conceivably, this
removal is mediated by interactions of PMap with leukocytes,
particularly monocytes. Indeed, coaggregates of platelet
fragments and monocytes could be detected in blood from
healthy subjects (E. Vasina, unpublished data). On the other
hand, such interactions may contribute to long-term leukocyte
differentiation, as we have pointed out in this paper, and can
even be a polarizing factor in the development of resident
monocytes. However, further work needs to be done to
demonstrate that PMap-primed monocytes differentiate into
M2 cells and resident macrophages/dendritic cells in vivo.
The present results even suggest that PMap have an
immunomodulating potential by stimulating their own phago-
cytic removal, as CD11b, CD14
34 and CD36
25 all have been
implicated in the uptake of apoptotic material. This suggestion
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Cell Death and Diseaseis conﬁrmed by the plethora of proinﬂammatory and non-
inﬂammatory cytokines, including G-CSF, GM-CSF and TNFa,
that are secreted by PMap contact with monocytes. In conclusion,
this is the ﬁrst study to demonstrate that microparticles
spontaneously arising from apoptotic platelets are able to
promote monocytes towards a resident phagocytic phenotype,
changing their behavior and activation state, thus, presenting a
novel mechanism in which platelets and their products might
inﬂuence the progression of atherosclerotic disease.
Materials and Methods
Monocytic cells and primary monocytes. Human acute monocytic
leukemia THP-1 cells were cultured in RPMI-1640 medium with L-glutamine and
10% fetal bovine serum (FBS). MCs were obtained from buffy coats of peripheral
blood from healthy human donors who gave informed consent. Monocytes were
separated from neutrophils by Ficoll density gradient centrifugation and further
isolated by negative selection using a MACS Monocyte isolation kit II (Miltenyi
Biotech, Bergisch Gladbach, Germany), according to the manufacturer’s protocol.
Purity of the monocyte preparation was analyzed by ﬂow cytometry based on cell
forward scatter and side scatter and amounted to 497%.
Platelet-derived microparticles and washed platelets. PMap were
isolated from platelet concentrates in plasma, which were stored for 5 days under
standard blood bank conditions (Uniklinikum Aachen, Germany). Platelets were
removed by rapid centrifugation at 4000 g for 5min. The platelet-free plasma
preparations were centrifuged at 20000 g for 60min. Pellets containing PMap
were resuspended in Hepes buffer pH 7.45 (136mmol/l NaCl, 10mmol/l Hepes,
2.7mmol/l KCl, 2mmol/l MgCl2, 0.1% bovine serum albumin and 0.1% glucose),
ﬁltered through a 0.8-mm ﬁlter in order to remove residual platelets, and pelleted
again at 20000 g for 40min. Supernatants were used for control experiments.
After resuspension of the pellet in Hepes buffer, PMap labeled with anti-CD61-FITC
mAb(BDBiosciences,Heidelberg,Germany)werecountedbyﬂowcytometryinthe
presence of ﬁxed numbers of 6mm calibration beads (BD Biosciences). Event sizes
were estimated by addition of 1mm and 6mm ﬂuorescent beads (Polysciences,
Eppelheim, Germany). The CD61-positive events o6mm were counted as PMap.
Suspensions of PMap were directly used or snap-frozen in liquid nitrogen. The
isolated PMap were virtually negative for the exosome marker CD63.
Platelets were isolated from freshly obtained human blood, as described.
35
Flow cytometric determination of cell surface markers. Using ﬂow
cytometry on a ﬂuorescence-activated cell sorting Canto II (BD Biosciences),
platelets and PMap were characterized for surface protein levels with ﬂuorescently
labeled antibodies against CD61, CD62P or activated GPIIb/IIIa (PAC-1mAb; BD
Biosciences). Expression of phosphatidylserine was probed with APC-annexin A5
(BD Biosciences). THP-1 cells or monocytes in suspension were stained (30min,
41C) with mouse anti-human antibodies against CD11b, CD31 (Sigma, St. Louis,
MO, USA); CD14, CD16, CCR2, CCR5, CXCR4 (BD Biosciences); or CD36
(ImmunoTools, Friesoythe, Germany) and prepared as described before.
36
Intracellular CD68 was detected in cells ﬁxed with paraformaldehyde,
permeabilized with 0.5% Triton-X-100, and stained with mouse anti-human
CD68mAb (BD Biosciences). Corresponding negative control antibodies were
IgG1 (Sigma); IgG2b, k (BD Biosciences) or IgG2a (ImmunoTools) and used at
recommended dilutions. Expression levels are presented as geometric means of
ﬂuorescence histograms, corrected for the values obtained with isotype control
antibodies and as representative histograms (FlowJo software, Tree Star, Inc.,
Ashland, OR, USA).
Adhesion of monocytic cells. Adhesion of THP-1 cells was measured in
RPMI-1640 medium supplemented with 5% FBS, as described.
37 Cells treated with
vehicle,PMA(10ng/ml,Calbiochem,Darmstadt,Germany),plateletsorPMap,were
leftto adhereto ﬁbronectin-coatedwells at 371C.At indicatedtimes,vitalcellswere
labeled with BCECF acetoxymethyl ester (1mg/ml, Sigma) for 1h, after which
ﬂuorescence was measured of all cells and of adherent cells after a wash, using a
Spectra FluoPlus reader (Tecan, Ma ¨nnedorf, Switzerland). Adhesion was
expressed as percentage of ﬂuorescence of all cells. Incubations were performed
in triplicate. In parallel experiments, labeled cells were scraped from wells and
counted via calibrated ﬂow cytometry, with essentially the same results.
Adhesion of primary monocytes to a monolayer of human aorta endothelial cells
(passage 6–7) under ﬂow conditions (0.1ml/min, 1.5dynes/cm
2) was measured by
microscopic video imaging.
17 Cells were preincubated with Hepes buffer (vehicle),
PMap or platelets for 44h at 371C. During perfusion adherent monocytes were
counted in at least ﬁve random microscopic ﬁelds.
Transwell cell migration assay. In 5-mm pore Transwell plates (Corning
Life Sciences, Lowell, MA, USA), bottom chambers were ﬁlled with vehicle, CCL2
(50ng/ml, PeproTech, Hamburg, Germany) or PMap (10
8cells/ml) alone, or
coincubated with isotype control (IgG1) or blocking antibodies against CCL5 or
CXCL7 (10mg/ml, 40min at RT, all from R&D Systems, Minneapolis, MN, USA) in
RPMI-1640medium.UpperchamberscontainedTHP-1cellsinRPMI-1640medium
with 5% FBS (3 10
4cells/well). After 24h incubation at 371C, the cells in bottom
and upper wells were counted by calibrated ﬂow cytometry.
38 Assays were run in
triplicate. Percentages of transmigrated cells were calculated. Total cell counts
remained unchanged at the various incubation conditions.
Monocytecellfunctionassays. ProliferationofTHP-1cellswasmeasured
after culturing in RPMI-1640 medium with 5% FBS at 371C. Cells were seeded into 96-
well plates (3 10
4cells/well, or 1.5 10
5cells/ml), coated with ﬁbronectin and
stimulated, as described. At indicated times, adherent cells were labeled with DAPI
(0.5mg/mlfor1hat371C),andﬂuorescencewasmeasuredinaSpectraFluoPlusplate
reader. Calibrations with known cell counts were performed to convert ﬂuorescence
values to cell numbers. In parallel, fractions of viable cells were determined
microscopically by staining viable cells with calcein acetoxymethyl ester (1mg/ml) and
counter-staining leaky, non-viable cells with ethidium bromide (1mg/ml). Fractions of
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Figure 7 Secretomeproﬁleandconcentrationanalysisofcytokinemediators
produced by monocytes interacting with PMap or platelets. Monocytes on
ﬁbronectin-coated plates (3 10
5cells/well, or 1.5 10
6cells/ml) were coincu-
bated with vehicle control (ctrl), PMap (1.5 10
7cells/ml) or resting platelets (plts,
1.5 10
7cells/ml) for 44h. Supernatants were analyzed (a) for a panel of bioactive
mediators using a cytokine array kit, and data were expressed as percentage
differences compared with a vehicle control or (b) concentration determination of
C5a, GM-CSF, IFN-g and TNFa by conventional ELISA. Mean±S.E.M. (n¼3),
*Po0.05 versus control, 1Po0.05 versus platelets
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Cell Death and Diseasenon-viableTHP-1cellswereo0.3%after44hand6–7%after7days,regardlessofthe
presence or absence of PMA, platelets or PMap.
Binding and uptake of oxLDL was determined in 24-well plates. THP-1 cells
(8 10
5cells/ml) were incubated with PMap (8 10
6cells/ml), resting platelets
(8 10
6cells/ml) or PMA (10ng/ml). At time points of interest, DiI (1,10,di-octa-
decyl-3,3,3030-tetramethylindocarbocyanine perchlorate)-labeled oxLDL (25mg/ml)
was coincubated for 4h. After labeling, adherent cells were resuspended in
phosphate-bufferedsalinecontaining5mmol/lethylenediaminetetraaceticacid,and
left for 15min at room temperature (RT) to allow dissociation of surface-bound
oxLDL. After a wash step (centrifugation at 300 g for 10min), ﬂuorescence was
analyzed by ﬂow cytometry (phycoerythrin channel). Oxidized LDL and DiI-labeled
oxLDL were prepared from pooled human plasma and labeled as described.
39
Actin ﬁlaments in cultured THP-1 cells were determined after ﬁxation,
permeabilization and staining with ﬂuorescently labeled FITC (ﬂuorescein
isothiocyanate)-phalloidin (1mg/ml for 15min, Invitrogen, Darmstadt, Germany),
as described before.
10
Determination of monocyte cell secretion products. To assess for
secreted MMP, cell supernatants were subjected to acrylamide gel electrophoresis,
and the collagenolytic activity in gels was determined by classical zymography.
Produced H2O2 in cell supernatants was quantiﬁed from the conversion rate of
tetramethylbenzidine substrate with a kit from Calbiochem.
Human primary monocytes in ﬁbronectin-coated well plates were incubated with
PMap or platelets for 44h (371C). Supernatants were analyzed for secreted
mediators using a commercial human cytokine array kit (R&D Systems) for
proteome proﬁling of secreted cytokines or conventional ELISA kits for C5a (R&D
Systems), GM-CSF (PeproTech), IFN-g and TNFa (both from eBioscience, San
Diego, CA, USA).
Electron and confocal microscopy. Platelets or PMap, alone or
coincubated with THP-1 cells, were immobilized on poly-lysine surfaces, and ﬁxed
with 4% paraformaldehyde. After overnight dehydration, samples were subjected to
scanning electron microscopy, as described.
40 PMap were labeled with anti-human
CD61-FITC mAb (BD Biosciences) for 1h and then coincubated with THP-1 cells
(1 10
6cells/ml)for4h.Afterwards,thecellswerelabeledwithaleukocytemarkeranti-
human CD45-APC mAb (eBioscience) for 40min (all incubations at RT). Finally, the
cells were mounted on a coverslip without ﬁxation and visualized using a 2100 MP
(Bio-Rad, Hercules, CA, USA) microscope set in confocal mode.
Statistical analyses. Data are given as mean±S.E.M. Differences with
Po0.05wereconsideredtobestatisticallysigniﬁcant(Student’st-testoranalysisof
variance where applicable).
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